Anthony Martinelli is founder and Editor-in-Chief of The Marijuana Herald. Anthony previously served as Editor-in-Chief of TheJointBlog.com (a cannabis news site he founded in 2011 and sold in 2019), and he has worked as a campaign manager and communications director for multiple political campaigns and elected officials. Anthony can be reached at Info@TheMarijuanaHerald.com.
Author's posts
New Hampshire House Approves Bill to Legalize Medical Psilocybin
New Hampshire’s full House of Representatives has voted to approve House Bill 1809, a measure that would authorize the medical use of psilocybin through a state-run program overseen by the Department of Health and Human Services. The bill will now move to the Senate for consideration.
Marijuana’s Polyphenols Help Neurons Flip On Their Antioxidant Defenses, Study Finds
According to a study published by the journal Biomedicine & Pharmacotherapy, a polyphenol-rich extract from Cannabis sativa may help nerve-like cells defend themselves against oxidative stress, a biological process widely linked to neurodegenerative diseases such as Alzheimer’s, Parkinson’s, ALS and primary lateral sclerosis.
Study: CB2 Activation May Reduce Lung Injury Caused by COVID-19
A new study published in the journal Lung by researchers at Eastern Virginia Medical School at Old Dominion University reports that activating the cannabinoid type 2 receptor (CB2) may help prevent lung damage caused by COVID-19.
Connecticut Marijuana Sales Top $24 Million in January, Prices Down Over 25% From Previous January
Connecticut’s legal marijuana market recorded $24,489,080 in total sales in January 2026, with $19,006,752 coming from adult-use purchases and $5,482,328 from medical marijuana. The combined figure is above the $23,585,404 sold in January 2025, an increase of $903,676, or about 3.8%.
CBD May Help Limit the “Second Wave” of Brain Damage After Traumatic Brain Injury, Study Finds
A new study published in Current Opinion in Toxicology by researchers from Gazi University says cannabidiol (CBD) may have potential as a treatment to blunt the delayed “secondary wave” of damage that can follow traumatic brain injury (TBI).
CB1 Activation Helps Speed Wound Healing, Reports Study
Researchers from Hallym University and Eulji University in the Republic of Korea report that activating cannabinoid receptor 1 (CB1) boosted several key wound-healing processes in human skin cells and accelerated wound closure in mice, according to findings published in International Journal of Molecular Sciences.
Florida Senate Committee to Vote Feb. 18 on Bill Tightening Low-THC Marijuana Rules and Expanding Buffer Zones for Dispensaries
Florida’s Senate Appropriations Committee is preparing to vote on a bill that would tighten rules around low-THC marijuana products and where medical marijuana businesses can operate. The committee has scheduled Senate Bill 902 for a vote on February 18 at 8:30 a.m., after the measure sailed through the Health Policy Committee on Wednesday in an …
Study: CBD Kills Rare Ovarian Tumor Cells by Targeting TRPV2 Channel and Mitochondrial Pathway
A new study reports that cannabidiol (CBD), a non-intoxicating component of marijuana, may exploit a specific ion channel and a mitochondrial pathway to kill cells from a rare type of ovarian tumor.
Edible Hemp Film Helped Keep Freeze-Dried Berries Fresher in Storage, Study Finds
A study published in Molecules examined whether adding cannabis extract to polysaccharide-based films could better protect freeze-dried raspberries and blueberries during storage. The team produced several versions of the film with different extract levels, then evaluated how the extract changed the film’s physical performance and how well it preserved the fruit over time.
Maryland Cannabis Industry Generates $98.9 Million in Sales in January, Prices down 12% from January 2025
Maryland’s marijuana industry recorded $98.9 million in total sales for January 2025, according to newly released data from the Maryland Cannabis Administration. This marks a nearly 5% increase from the $94.5 million sold in January 2025, despite prices seeing a significant drop.












